TXT
65
-3
ADSK
45
-5
GILD
28
-2
DVN
44
-2
BSX
64
-2
INTC
45
-3
APA
48
2
AMAT
58
-3
ORCL
59
-3
CNP
54
2
F
42
2
CMS
53
3
FMC
39
2
PCG
77
5
AMG
38
-2
MS
58
3
SLG
71
5
IP
47
8
KMB
39
-6
GPC
48
-5
TXT
65
-3
ADSK
45
-5
GILD
28
-2
DVN
44
-2
BSX
64
-2
INTC
45
-3
APA
48
2
AMAT
58
-3
ORCL
59
-3
CNP
54
2
F
42
2
CMS
53
3
FMC
39
2
PCG
77
5
AMG
38
-2
MS
58
3
SLG
71
5
IP
47
8
KMB
39
-6
GPC
48
-5
Financhill
Back

DexCom Quote, Financials, Valuation and Earnings

He cracked the code to crypto

Now he says a new two-year bull market has begun. And he likes one altcoin above all others.
Buy
65

DXCM
DexCom

Last Price:
134.60
Seasonality Move:
13.1%

7 Day Trial

ALL ACCESS PASS

$ 7

Stock Market Legend Shares Biggest Prediction Ever:

Click Here to See

DexCom Price Quote

$134.60
+0.74 (+0.55%)
(Updated: April 18, 2024 at 3:15 PM ET)

DexCom Key Stats

Buy
65
DexCom (DXCM) is a Buy
Day range:
$132.88 - $136.64
52-week range:
$74.75 - $142.00
Dividend yield:
0%
P/E ratio:
102.89
P/S ratio:
15.64
P/B ratio:
24.93%
Volume:
2.6M
Avg. volume:
2.9M
1-year change:
12.82%
Market cap:
$51.6B
Revenue:
$3.6B
EPS:
$1.31

How Much Does DexCom Make?

  • How Much Are DexCom's Sales Annually?
    DXCM Revenues are $3.6B
  • How Much Profit Does DexCom's Make A Year?
    DXCM net income is $541.5M

Is DexCom Growing As A Company?

  • What Is DexCom's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.27%
  • What Is DexCom's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 1.82%

DexCom Stock Price Performance

  • Did DexCom Stock Go Up Last Month?
    DexCom share price went up by 2.61% last month
  • Did DXCM's Share Price Rise Over The Last Year?
    DXCM share price rose by 12.82% over the past 1 year

What Is DexCom 52-Week High & Low?

  • What Is DexCom’s 52-Week High Share Price?
    DexCom has traded as high as $142.00 over the past 52 weeks
  • What Is DexCom’s 52-Week Low Share Price?
    DexCom has traded as low as $74.75 over the past 52 weeks

DexCom Price To Free Cash Flow

  • Is DexCom Stock Overvalued?
    DexCom is trading at a price to free cash flow ratio of 110.65
  • Is DexCom Stock Undervalued?
    DexCom EV to Free Cash Flow ratio is 102.25
  • What Is DexCom’s Price Earnings Growth Ratio?
    DXCM PEG ratio is 1.65
  • Is DexCom Trading At A Premium To Earnings?
    DexCom EV to EBIT ratio is 71.63

Is It Risky To Buy DexCom?

  • How Much Debt Does DexCom Have?
    Total long term debt quarterly is $2.4B
  • How Much Cash Does DexCom Have?
    Cash and short term investments quarterly total is $2.7B
  • What Is DexCom’s Book Value Per Share?
    Book value per share is 5.37

Is DexCom Cash Flow Positive?

  • What Is DXCM Cash Flow From Operations?
    Cash flow from operations (TTM) is $748.5M
  • What Is DexCom’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$318.6M
  • What Is DexCom’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$507.2M

DexCom Return On Invested Capital

  • Is Management Doing A Good Job?
    DXCM return on invested capital is 11.8%
  • What Is DexCom Return On Assets?
    ROA measures how assets are converting to revenues and is 8.85%
  • What Is DXCM Return On Equity?
    ROE is a measure of profitability and is 25.07%

DexCom Earnings Date & Stock Price

  • What Is DexCom's Stock Price Today?
    A single share of DXCM can be purchased today for 133.86
  • What Is DexCom’s Stock Symbol?
    DexCom trades on the nasdaq under the ticker symbol: DXCM
  • When Is DexCom’s Next Earnings Date?
    The next quarterly earnings date for DexCom is scheduled on April 25, 2024
  • When Is DXCM's next ex-dividend date?
    DexCom's next ex-dividend date is May 1, 2020
  • How To Buy DexCom Stock?
    You can buy DexCom shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

DexCom Competitors

  • Who Are DexCom's Competitors?
    Below is a list of companies who compete with DexCom or are related in some way:
    • Abbott Laboratories (ABT)
    • Edwards Lifesciences Corp (EW)
    • Intuitive Surgical Inc (ISRG)
    • Integer Holdings Corp (ITGR)
    • Stryker Corp (SYK)

DexCom Dividend Yield

Data Unavailable

DexCom Analyst Estimates

YoY Growth Past Surprise
EPS: 181.82% 16.01%
Revenue: 26.9% 1.25%

Analyst Recommendations

Buy Recommendations: 18
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 149.29
Upside from Last Price: 11.53%

Major Shareholders

  • How many DXCM shares are owned by institutional investors?
    615.7M DXCM shares are owned by institutional investors
  • How many DXCM shares are owned by insiders?
    2.7M DXCM shares are owned by insiders